Occluded Artery Trial: Long Term Follow-Up
动脉闭塞试验:长期随访
基本信息
- 批准号:7871492
- 负责人:
- 金额:$ 56.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-30 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAncillary StudyArteriesAwardBenefits and RisksCardiologyCardiovascular DiseasesCaringCategoriesCessation of lifeCharacteristicsClinicalClinical ResearchClinical TrialsCollaborationsCommunitiesCompanionsComplexCongestive Heart FailureCoronary OcclusionsCoronary arteryCountryDataData AnalysesData Coordinating CenterDatabasesDevelopmentEFRACEconomicsElectrocardiogramEnrollmentEventFunctional disorderFundingGrantGuidelinesHealthHospitalizationHoward Temin AwardInfarctionInternationalInvestigationInvestmentsLaboratoriesLeadershipLeft Ventricular FunctionLeft Ventricular RemodelingLocationMarylandMedicalMedical ResearchMedical centerMyocardial InfarctionNational Heart, Lung, and Blood InstituteNew YorkOutcomePatientsPhasePopulationProceduresQuality of lifeRaceRandomizedRecurrenceResearch InstituteResearch PersonnelResourcesRiskRisk FactorsSF-36SiteSpecific qualifier valueSubgroupSymptomsTestingTimeUnited States National Institutes of HealthUniversitiesWeightWell in selfWorkacute coronary syndromeadjudicatearmartery occlusionbaseclinical research sitecohortcostdesignexhaustfollow-upfunctional statushigh riskinsightmedical schoolsoperationoutcome forecastpercutaneous coronary interventionprimary outcomeprogramsrandomized trialrepairedsextreatment strategytrend
项目摘要
DESCRIPTION (provided by applicant):
The Occluded Artery Trial (OAT) is an NHLBI-funded international, multicenter, randomized trial testing the hypothesis that percutaneous coronary intervention with optimal medical therapy is superior in reducing clinical events compared to optimal medical therapy alone in stable, but high-risk, post-myocardial infarction patients. OAT patients have totally occluded infarct-related arteries 3-28 days after myocardial infarction (Ml) and at least one additional high risk feature, either reduced left ventricular function (ejection fraction < 50%) or proximal coronary artery occlusion. Patients were randomized between 2000 and 2005 to either medical management or medical management plus percutaneous coronary intervention and stenting. The primary endpoint was a composite of death, class IV congestive heart failure (CHF) and recurrent Ml. After an average of three years of follow up of 2,166 enrolled patients, there was no significant difference between the treatment groups for the primary endpoint. This application for a competitive renewal proposes: A) to extend follow up by an additional 3 years to achieve an average follow up of approximately 6 years on the OAT cohort to examine late trends in events and quality of life and B) to perform additional in depth analyses on the original OAT cohort followed by 3 years. Extended follow up will also increase power to examine prespecified subgroups. Extension of follow up in OAT is designed to provide the medical community with definitive data on the risks and benefits of a strategy of routine PCI of persistently occluded infarct-related arteries in stable patients last post-Mi.
OAT has over 200 participating clinical sites, a Clinical Coordinating Center (CCC) at New York University Medical School, a Co-CCC at Mount Sinai Medical Center (Miami), a Data Coordinating Center (DCC) at Maryland Medical Research Institute and an Economics and Quality of Life Coordinating Center at Duke Clinical Research Institute.
描述(由申请人提供):
项目成果
期刊论文数量(29)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Angiographic and clinical outcomes of drug-eluting versus bare metal stent deployment in the Occluded Artery Trial.
- DOI:10.1002/ccd.21930
- 发表时间:2009-05-01
- 期刊:
- 影响因子:2.3
- 作者:Dzavik, Vladimir;Buller, Christopher E.;Devlin, Gerard;Carere, Ronald G.;Mancini, G. B. John;Cantor, Warren J.;Buszman, Pawel E.;Rankin, James M.;Vozzi, Carlos;Ross, John R.;Forman, Sandra;Barton, Bruce A.;Lamas, A. Gervasio A.;Hochman, Judith S.
- 通讯作者:Hochman, Judith S.
Myocardial perfusion grade after late infarct artery recanalization is associated with global and regional left ventricular function at one year: analysis from the Total Occlusion Study of Canada-2.
晚期梗死动脉再通后的心肌灌注等级与一年时的整体和区域左心室功能相关:来自 Canada-2 完全闭塞研究的分析。
- DOI:10.1161/circinterventions.109.918722
- 发表时间:2010
- 期刊:
- 影响因子:0
- 作者:Steigen,TerjeK;Buller,ChristopherE;Mancini,GBJohn;Jorapur,Vinod;Cantor,WarrenJ;Rankin,JamesM;Thomas,Boban;Webb,JohnG;Kronsberg,ShariS;Atchison,DeborahJ;Lamas,GervasioA;Hochman,JudithS;Dzavik,Vladimir
- 通讯作者:Dzavik,Vladimir
Percutaneous revascularization and long term clinical outcomes of diabetic patients randomized in the Occluded Artery Trial (OAT).
动脉闭塞试验 (OAT) 中随机分配的糖尿病患者的经皮血运重建和长期临床结果。
- DOI:10.1016/j.ijcard.2013.02.004
- 发表时间:2013
- 期刊:
- 影响因子:3.5
- 作者:Overgaard,ChristopherB;Džavík,Vladimír;Buller,ChristopherE;Liu,Li;Banasiak,Waldemar;Devlin,Gerard;Maggioni,AldoP;Leor,Jonathan;Burton,JefferyR;Reis,Gilmar;Ruzyllo,Witold;Forman,SandraA;Lamas,GervasioA;Hochman,JudithS;OAT
- 通讯作者:OAT
Relationship of female sex to outcomes after myocardial infarction with persistent total occlusion of the infarct artery: analysis of the Occluded Artery Trial (OAT).
女性性别与梗塞动脉持续完全闭塞的心肌梗塞后结局的关系:闭塞动脉试验(OAT)分析。
- DOI:10.1016/j.ahj.2012.01.005
- 发表时间:2012
- 期刊:
- 影响因子:4.8
- 作者:Reynolds,HarmonyR;Forman,SandraA;Tamis-Holland,JacquelineE;Steg,PhilippeGabriel;Mark,DanielB;Pearte,CamilleA;Carvalho,AntonioC;Sopko,George;Liu,Li;Lamas,GervasioA;Kruk,Mariusz;Loboz-Grudzien,Krystyna;Ruzyllo,Witold;Hochma
- 通讯作者:Hochma
Impact of percutaneous coronary intervention on biomarker levels in patients in the subacute phase following myocardial infarction: the Occluded Artery Trial (OAT) biomarker ancillary study.
经皮冠状动脉介入治疗对心肌梗死后亚急性期患者生物标志物水平的影响:闭塞动脉试验(OAT)生物标志物辅助研究。
- DOI:10.1186/1471-2261-13-91
- 发表时间:2013
- 期刊:
- 影响因子:2.1
- 作者:Kruk,Mariusz;Menon,Venu;Kądziela,Jacek;Sadowski,Zygmunt;Rużyłło,Witold;Janas,Jadwiga;Roik,Marek;Opolski,Grzegorz;Zmudka,Krzysztof;Czunko,Piotr;Kurowski,Michal;Busz-Papież,Benita;Zinka,Elzbieta;Jablonski,Wojciech;Jaworska,Kryst
- 通讯作者:Jaworska,Kryst
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Judith S Hochman其他文献
1118-102 Baseline white blood cell count and interleukin-6 levels provide complementary prognostic information in acute myocardial infarction: Results from the CARDINAL trial
- DOI:
10.1016/s0735-1097(04)91234-x - 发表时间:
2004-03-03 - 期刊:
- 影响因子:
- 作者:
Manesh R Patel;Kenneth W Mahaffey;Paul W Armstrong;W.Douglas Weaver;Gudaye Tasissa;Judith S Hochman;Thomas G Todaro;Kevin J Malloy;Thomas H Parish;Scottt Rollins;Pierre Theroux;Wiltold Ruzyllo;Jose C Nicolau;Christopher B Granger - 通讯作者:
Christopher B Granger
869-4 Sex disparities in the treatment of non-ST-segment elevation acute coronary syndromes
- DOI:
10.1016/s0735-1097(04)91286-7 - 发表时间:
2004-03-03 - 期刊:
- 影响因子:
- 作者:
Andra L Blomkalns;L.Kristin Newby;Anita Chen;Eric D Peterson;Kelly Trynosky;Deborah Diercks;William E Boden;Matthew T Roe;E.Magnus Ohman;W.Brian Gibler;Judith S Hochman - 通讯作者:
Judith S Hochman
861-1 Direct, selective, factor Xa inhibition in patients with non-ST elevation acute coronary syndromes from the United States, Canada, and Japan: Results of the XaNADU-ACS trial
- DOI:
10.1016/s0735-1097(04)91279-x - 发表时间:
2004-03-03 - 期刊:
- 影响因子:
- 作者:
John H Alexander;Hongqiu Yang;Richard C Becker;Kazuhisa Kodama;Christopher K Dyke;Shaun G Goodman;Neal S Kleiman;Judith S Hochman;Peter B Berger;Eric A Cohen;Michael Lincoff;Edwin G Bovill;Chuichi Kawai;Paul W Armstrong;Robert A Harrington - 通讯作者:
Robert A Harrington
Judith S Hochman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Judith S Hochman', 18)}}的其他基金
The International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial EXTENDed Follow-up (EXTEND)
医疗和侵入性方法的比较健康有效性国际研究 (ISCHEMIA) 试验延长随访 (EXTEND)
- 批准号:
10611880 - 财政年份:2021
- 资助金额:
$ 56.56万 - 项目类别:
The International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial EXTENDed Follow-up (EXTEND)
医疗和侵入性方法的比较健康有效性国际研究 (ISCHEMIA) 试验延长随访 (EXTEND)
- 批准号:
10379246 - 财政年份:2021
- 资助金额:
$ 56.56万 - 项目类别:
OCCLUDED ARTERY TRIAL--CLINICAL COORDINATING CENTER
动脉闭塞试验--临床协调中心
- 批准号:
7225839 - 财政年份:1999
- 资助金额:
$ 56.56万 - 项目类别:
OCCLUDED ARTERY TRIAL--CLINICAL COORDINATING CENTER
动脉闭塞试验--临床协调中心
- 批准号:
6390334 - 财政年份:1999
- 资助金额:
$ 56.56万 - 项目类别:
相似海外基金
Coronary Artery Calcium in the PRagmatic EValuation of evENTs And Benefits of Lipid lowering in the Elderly: CAC PREVENTABLE Ancillary Study
冠状动脉钙对老年人降脂事件和益处的实用评估:CAC 可预防的辅助研究
- 批准号:
10674482 - 财政年份:2021
- 资助金额:
$ 56.56万 - 项目类别:
A Longitudinal Study of Periodontal Infections and Alzheimer's Disease: The WHICAP Ancillary Study of Oral Health
牙周感染和阿尔茨海默病的纵向研究:口腔健康的 WHICAP 辅助研究
- 批准号:
10381292 - 财政年份:2021
- 资助金额:
$ 56.56万 - 项目类别:
The PREVENTABLE Physical Performance Ancillary Study
可预防的身体表现辅助研究
- 批准号:
10366941 - 财政年份:2021
- 资助金额:
$ 56.56万 - 项目类别:
The PREVENTABLE Physical Performance Ancillary Study
可预防的身体表现辅助研究
- 批准号:
10495229 - 财政年份:2021
- 资助金额:
$ 56.56万 - 项目类别:
StAtins Use in intRacereberal hemorrhage patieNts MRI (SATURN MRI) Ancillary Study
他汀类药物在脑出血患者中的使用 MRI (SATURN MRI) 辅助研究
- 批准号:
10179775 - 财政年份:2021
- 资助金额:
$ 56.56万 - 项目类别:
Mechanistic Ancillary Study to the Natural History Study of ADO2 to Determine Clinical Severity
ADO2 自然史研究的机制辅助研究以确定临床严重程度
- 批准号:
10375070 - 财政年份:2021
- 资助金额:
$ 56.56万 - 项目类别:
A Longitudinal Study of Periodontal Infections and Alzheimer's Disease: The WHICAP Ancillary Study of Oral Health
牙周感染和阿尔茨海默病的纵向研究:口腔健康的 WHICAP 辅助研究
- 批准号:
10631203 - 财政年份:2021
- 资助金额:
$ 56.56万 - 项目类别:
Coronary Artery Calcium in the PRagmatic EValuation of evENTs And Benefits of Lipid lowering in the Elderly: CAC PREVENTABLE Ancillary Study
冠状动脉钙对老年人降脂事件和益处的实用评估:CAC 可预防的辅助研究
- 批准号:
10296788 - 财政年份:2021
- 资助金额:
$ 56.56万 - 项目类别:
COCOA PAD II Trial: Microbiome Ancillary Study
COCOA PAD II 试验:微生物组辅助研究
- 批准号:
10610072 - 财政年份:2021
- 资助金额:
$ 56.56万 - 项目类别:
An MRI Ancillary Study of Malaria Fever Control RCT
疟疾发热控制的 MRI 辅助随机对照试验
- 批准号:
10343754 - 财政年份:2020
- 资助金额:
$ 56.56万 - 项目类别:














{{item.name}}会员




